Search Results - "Yu, Yun‐Suk"
-
1
A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets
Published in Biomedicines (16-01-2022)“…Innate and adaptive immune responses are critically associated with the progression of fibrosis in chronic liver diseases. In this study, we aim to identify a…”
Get full text
Journal Article -
2
Epithelial–mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma
Published in Cancer science (01-06-2010)“…Hepatocellular carcinoma is one of the most lethal cancers worldwide. More accurate stratification of patients at risk is necessary to improve its clinical…”
Get full text
Journal Article -
3
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
Published in Journal of experimental & clinical cancer research (16-02-2009)“…Hepatocellular carcinoma (HCC) is the most common tumor in the adult liver, with high relapse and mortality rates despite diverse treatment modalities. In this…”
Get full text
Journal Article -
4
Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas
Published in Annals of surgical treatment and research (01-12-2018)“…OncoHepa test is a multigene expression profile test developed for assessment of hepatocellular carcinoma (HCC) prognosis. Multiplication of α-FP,…”
Get full text
Journal Article -
5
Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis
Published in Cells (Basel, Switzerland) (26-10-2022)“…Intrahepatic mononuclear phagocytes (MPs) are critical for the initiation and progression of liver fibrosis. In this study, using multiplexed digital spatial…”
Get full text
Journal Article -
6
Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker
Published in Liver cancer (Basel ) (01-04-2020)“…Background/Aim: Uniform treatment of hepatocellular carcinoma (HCC) with molecular targeted drugs (e.g., sorafenib) results in a poor overall tumor response…”
Get full text
Journal Article -
7
Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma
Published in PloS one (13-06-2013)“…The effectiveness of molecular targeted agents is modest in hepatocellular carcinoma (HCC). Efficacy of molecular targeted therapies has been better in cancer…”
Get full text
Journal Article -
8
Multiplexed digital spatial protein profiling reveals potential non-invasive biomarkers to predict advanced fibrosis
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
9
RNA sequencing analysis and T-cell receptor repertoire in triple-negative breast cancer (TNBC)
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 1075 Background: Triple negative breast cancer (TNBC) is defined by the lack of two hormone receptors (HR) and human epidermal growth factor…”
Get full text
Journal Article -
10
A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer
Published in Cancer research and treatment (01-10-2024)“…Triple-negative breast cancer (TNBC) is a particularly challenging subtype of breast cancer, with a poorer prognosis compared to other subtypes. Unfortunately,…”
Get full text
Journal Article -
11
Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma
Published in Journal of cancer research and clinical oncology (01-09-2014)“…Purpose Although transcatheter arterial chemoembolization (TACE) is the most common treatment option in patients with hepatocellular carcinoma (HCC), its…”
Get full text
Journal Article -
12
A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Published in Cancers (26-03-2020)“…Preoperative chemoradiotherapy (PCRT) and subsequent surgery is the standard multimodal treatment for locally advanced rectal cancer (LARC), albeit PCRT…”
Get full text
Journal Article -
13
Abstract P2-11-25: A 10-gene signature to predict the prognosis of early-stage triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Background: Triple-negative breast cancer (TNBC) is highly heterogeneous cancer and the most challenging subtype of breast cancer. And its prognosis is poor…”
Get full text
Journal Article -
14
Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1[alpha] pathway in patients with hepatocellular carcinoma
Published in Journal of cancer research and clinical oncology (01-09-2014)“…Although transcatheter arterial chemoembolization (TACE) is the most common treatment option in patients with hepatocellular carcinoma (HCC), its clinical…”
Get full text
Journal Article -
15
Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma. e64260
Published in PloS one (01-06-2013)“…Background The effectiveness of molecular targeted agents is modest in hepatocellular carcinoma (HCC). Efficacy of molecular targeted therapies has been better…”
Get full text
Journal Article